Phase I trial of perillyl alcohol administered four times daily continuously.
Morgan-Meadows S, Dubey S, Gould M, Tutsch K, Marnocha R, Arzoomanin R, Alberti D, Binger K, Feierabend C, Volkman J, Ellingen S, Black S, Pomplun M, Wilding G, Bailey H.
Morgan-Meadows S, et al. Among authors: alberti d.
Cancer Chemother Pharmacol. 2003 Nov;52(5):361-6. doi: 10.1007/s00280-003-0684-y. Epub 2003 Aug 2.
Cancer Chemother Pharmacol. 2003.
PMID: 12904896
Clinical Trial.